首页> 美国卫生研究院文献>PLoS Computational Biology >Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
【2h】

Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features

机译:HIV-1 gp160序列特征预测VRC01中和敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The broadly neutralizing antibody (bnAb) VRC01 is being evaluated for its efficacy to prevent HIV-1 infection in the Antibody Mediated Prevention (AMP) trials. A secondary objective of AMP utilizes sieve analysis to investigate how VRC01 prevention efficacy (PE) varies with HIV-1 envelope (Env) amino acid (AA) sequence features. An exhaustive analysis that tests how PE depends on every AA feature with sufficient variation would have low statistical power. To design an adequately powered primary sieve analysis for AMP, we modeled VRC01 neutralization as a function of Env AA sequence features of 611 HIV-1 gp160 pseudoviruses from the CATNAP database, with objectives: (1) to develop models that best predict the neutralization readouts; and (2) to rank AA features by their predictive importance with classification and regression methods. The dataset was split in half, and machine learning algorithms were applied to each half, each analyzed separately using cross-validation and hold-out validation. We selected Super Learner, a nonparametric ensemble-based cross-validated learning method, for advancement to the primary sieve analysis. This method predicted the dichotomous resistance outcome of whether the IC50 neutralization titer of VRC01 for a given Env pseudovirus is right-censored (indicating resistance) with an average validated AUC of 0.868 across the two hold-out datasets. Quantitative log IC50 was predicted with an average validated R2 of 0.355. Features predicting neutralization sensitivity or resistance included 26 surface-accessible residues in the VRC01 and CD4 binding footprints, the length of gp120, the length of Env, the number of cysteines in gp120, the number of cysteines in Env, and 4 potential N-linked glycosylation sites; the top features will be advanced to the primary sieve analysis. This modeling framework may also inform the study of VRC01 in the treatment of HIV-infected persons.
机译:在抗体介导的预防(AMP)试验中,正在评估广泛中和的抗体(bnAb)VRC01预防HIV-1感染的功效。 AMP的第二个目的是利用筛分分析来研究VRC01预防功效(PE)如何随HIV-1包膜(Env)氨基酸(AA)序列特征而变化。测试PE如何充分依赖变化的每个AA功能的详尽分析将具有较低的统计功效。为了设计用于AMP的功能强大的主筛分析,我们将CATCAP数据库中611种HIV-1 gp160伪病毒的Env AA序列功能与VRC01中和模型化,其目标是:(1)建立能够最有效预测中和读数的模型; (2)使用分类和回归方法按其预测重要性对AA特征进行排名。将数据集分成两半,然后将机器学习算法应用于每一半,分别使用交叉验证和保留验证对它们进行分析。我们选择了基于非参数集成的交叉验证学习方法“超级学习者”,以进行初级筛分分析。该方法预测了对于给定的Env假病毒VRC01的IC50中和效价是否被右删截(指示耐药)的二分抗结果,在两个保留数据集中平均验证的AUC为0.868。预测定量对数IC50,平均有效R 2 为0.355。预测中和敏感性或抗性的功能包括VRC01和CD4结合足迹中的26个表面可及残基,gp120的长度,Env的长度,gp120中的半胱氨酸的数量,Env中的半胱氨酸的数量以及4个潜在的N-连接的糖基化位点;主要功能将升级到主要筛分分析。该建模框架还可以为VRC01在治疗HIV感染者中的研究提供参考。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号